Page 21 - SDIR5 Abstract book 21 12 2021.
P. 21

CANCER AND METABOLISM


                  Dual targeting of energy metabolism and lysosomes as an anticancer strategy; It is not all
                                                      about autophagy

                                                     2
                                                                    2
                                        1
                                                                                 2
                                                                                                 2
                  Ljubica Harhaji-Trajkovic , Milica Kosic , Verica Paunovic , Biljana Ristic , Mihajlo Bosnjak , Nevena
                                                                                 1
                                              2
                                                               1
                                                                                                   2
                                1
                         Zogovic , Milos Mandic , Gordana Tovilovic , Kristina Janjetovic , Vladimir Trajkovic
                1 Department of Neurophysiology, Institute for Biological Research “Sinisa Stankovic”-National Institute of Republic
                                          of Serbia, University of Belgrade, Belgrade, Serbia
                    2 Institute of Microbiology and Immunology, Faculty of Medicine, University of Belgrade, Belgrade, Serbia

               Background:  Intensive  proliferation  of  tumor  cells  consumes  a  lot  of  energy.  In  nutrient  deficiency
               substrates for energy metabolism are obtained by lysosomal degradation of unnecessary/dysfunctional
               intracellular organelles/molecules in the process of autophagy. Leakage of enlarged unstable lysosomes,
               which characterize tumor cells, causes cell death. We investigated antitumor effect of combined targeting
               of lysosomes/autophagy and energy metabolism. Material and Methods: Toxicity against U251 human
               glioma and B16 mouse melanoma cells was measured by viability tests. Type/mechanisms of cell death
               were  determined  by  flow  cytometry,  immunoblot,  fluorescent/electron  microscopy  and  confirmed  by
               appropriate genetic/pharmacological inhibitors. Therapeutic potential was estimated in B16 melanoma-
               bearing C57Bl/6 mice. Results: In the first study, lysosomotropic autophagy  inhibitor chloroquine (CQ)
               rapidly  killed  tumor  cells  incubated  in  the  absence  of  serum.  CQ-induced  lysosomal  destabilization
               triggered: oxidative stress, mitochondrial depolarization, and mixed apoptosis/necrosis of serum-deprived
               cells. In the second study, lysosomal detergent N-dodecylimidazole (NDI) synergized in antitumor activity
               with the glycolytic inhibitor 2-deoxy-D-glucose (2DG). NDI-triggered release of lysosomal enzymes into the
               cytoplasm caused mitochondrial damage and blocked oxidative phosphorylation, which synergized with
               2DG-mediated glycolysis block in ATP reduction, oxidative stress, and necrosis. Interestingly, although both
               serum  deprivation  and  2DG  stimulated  autophagy,  CQ-  and  NDI-induced  autophagy  suppression  was
               irrelevant for their cytotoxicity. Importantly, CQ+food restriction and 2DG+NDI reduced melanoma growth
               in vivo. Conclusion: Autophagy independent antitumor effects of combined energy metabolism suppression
               and lysosomal destabilization might be exploited in cancer therapy.

               Keywords: Autophagy; Combined Therapy; Energy Metabolism; Lysosomes.
















                                                              8
   16   17   18   19   20   21   22   23   24   25   26